Latest Breaking News On - Relievant medsystems - Page 2 : comparemela.com

Dave Amerson and Tyler Binney Add Their Experience Commercializing Disruptive Technologies to Intrinsic Therapeutics' Board of Directors

/PRNewswire/ Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and.

Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

Boston Scientific Corp (BSX) Posts Strong Q4 and Full Year 2023 Results

Revenue and Earnings Per Share Surge, Outpacing Market Expectations

Augmedics CEO takes over corner office at CVRx

CVRx (Nasdaq:CVRX) announced today that it appointed Kevin Hykes as its new president and CEO, effective Feb. 12.

The largest spine, orthopedic acquisitions of the last 5 years

"Discover the biggest spine and orthopedic acquisitions of the last five years, from healthcare systems to medical device companies, as reported by Becker s."